The Autism Market at a Crossroads
Aligning Growth with Person-Centered, Lifespan Care
Summary: The rapid expansion of autism-related services in the United States has been accompanied by increased investment from private equity and other for-profit entities. While this growth reflects rising prevalence, expanded diagnostic awareness, and improved insurance coverage, it also introduces tensions between financial incentives and the delivery of person-centered, high-quality care. This commentary explores the evolving autism services marketplace, highlighting both opportunities and risks. It argues that the central issue is not the presence of capital investment, but whether healthcare systems are structured to align financial incentives with meaningful clinical outcomes across the lifespan. A broader, integrated framework for neurodevelopmental care—spanning childhood through aging—is needed to ensure that growth in services translates into improved lives for individuals with autism and other intellectual and developmental disabilities (IDD).
Introduction: A Market in Motion
The landscape of autism services in the United States is undergoing rapid transformation. Rising prevalence rates, expanded screening efforts, and broader insurance mandates have contributed to a substantial increase in demand for services. At the same time, significant financial investment, particularly from private equity—has entered the autism treatment space, driving consolidation, expansion, and operational scaling of service delivery organizations (Oss, 2026).
This convergence of clinical need and financial opportunity has sparked an important and necessary debate: whether the growth of the autism services market is improving care or reshaping it in ways that may not fully serve those it intends to support.
Beyond a Binary Debate: Profit vs. Care
Discussions of private investment in healthcare are often framed as a binary tension between profit and patient care. However, this framing is overly simplistic and limits meaningful progress. A more constructive lens is to examine how systems incentivize behavior.
In the current autism services environment, reimbursement structures tend to reward the volume of services delivered, the intensity of interventions, and diagnostic eligibility. While these metrics are operationally meaningful, they do not adequately reflect outcomes that matter most to individuals and families, including functional independence, quality of life, caregiver stability, and long-term health trajectories (Agency for Healthcare Research and Quality [AHRQ], 2025). This disconnect contributes to a growing misalignment between what is measured and what is meaningful.
Market Growth and Emerging Distortions
The influx of capital into autism services has enabled rapid expansion, improving access in some regions while simultaneously introducing structural pressures. Care delivery models are increasingly designed for scalability and standardization, which may inadvertently limit individualized care. Service provision may also be influenced by reimbursement dynamics, with greater emphasis placed on higher-intensity or higher-revenue cases. Workforce restructuring has further shifted care models toward lower-cost staffing structures, and fragmentation between behavioral services and medical care systems persists (Mandell & Novak, 2021).
These developments are not necessarily the result of poor intent but rather reflect the influence of financial and operational incentives on care delivery. Without appropriate alignment, these forces may shape clinical practice in ways that diverge from person-centered principles.
The Missing Lens: Lifespan and Neurodevelopmental Complexity
A critical limitation of the current discourse is its narrow focus on pediatric behavioral services, particularly applied behavior analysis (ABA). While these services are essential, they represent only one dimension of a much broader clinical reality.
Autism is a lifelong neurodevelopmental condition frequently associated with epilepsy, psychiatric comorbidities, sleep disorders, and variability in cognitive and functional abilities. As individuals age, additional complexities emerge, including increased risk of neurodegenerative conditions such as dementia. Despite this, adult services and aging supports remain underdeveloped, creating a structural imbalance in which robust pediatric systems are not matched by equivalent adult care infrastructure (American Academy of Pediatrics, 2020).
At the same time, the broader population of individuals with intellectual and developmental disabilities risks being overshadowed by the concentration of resources within autism-specific services, further reinforcing disparities across the neurodevelopmental spectrum.
Capital in Care: Opportunity and Responsibility
Investment in healthcare is not inherently problematic. In many cases, it has facilitated expansion of access, infrastructure development, and innovation in service delivery. Capital can support the implementation of data-driven care models and reduce geographic disparities.
However, without appropriate guardrails, investment may also incentivize volume over value, standardization over individualization, and fragmentation over integration. Complex or lower-reimbursing individuals may be underserved, and longitudinal care needs may be insufficiently prioritized. The central challenge is therefore not the presence of capital, but whether financial incentives are aligned with outcomes that meaningfully improve lives.
Toward a National Consensus: Convening Leadership Across Sectors
A critical next step in addressing these challenges is the intentional convening of national leaders across clinical, advocacy, research, and service delivery domains. While the current evidence base does not support rigid, universally prescriptive models of care, it is sufficiently developed to inform consensus-based, evidence-informed guidance that defines ethical practice, appropriate utilization, and meaningful outcomes (National Institute for Health and Care Excellence, 2021).
Such an effort must be multidisciplinary and inclusive, bringing together clinicians, behavioral providers, self-advocates, families, payers, policymakers, and provider organizations, including those operating within for-profit models. The purpose of this convening would not be to restrict access to care, but to ensure that continued growth in autism services is guided by shared standards of quality, transparency, and accountability.
Equally important to the content of any consensus effort is the process by which it is developed. For guidance to be credible and durable, it must reflect meaningful engagement of stakeholders across individuals with autism, families and caregivers, providers, payers, investors, and policymakers. Authentic engagement strengthens legitimacy, surfaces perspectives that may otherwise be overlooked, and helps clarify real-world trade-offs inherent in system design and care delivery.
However, such engagement must be genuine. Processes perceived as predetermined, or dominated by expert authority alone, risk undermining trust and limiting impact. In contrast, thoughtfully facilitated and inclusive convenings create space for stakeholders to navigate complexity together and contribute meaningfully to defining what constitutes quality care. In the absence of this shared, consensus-driven approach, systems will continue to default to financial and operational incentives rather than person-centered outcomes.
Evolving National Leadership Landscape
Recent developments at the federal level further underscore the urgency of establishing a broadly trusted, consensus-driven framework. The restructuring of the Interagency Autism Coordinating Committee and the emergence of independent, science-focused advisory groups reflect a growing fragmentation of leadership across policy, research, and advocacy domains. While these efforts may serve important roles, they also highlight the absence of a unified, inclusive process that integrates scientific rigor with meaningful stakeholder engagement. This evolving landscape reinforces the need for a convening model that is both scientifically grounded and broadly representative, ensuring that future guidance reflects not only evidence, but also the lived experiences and priorities of individuals with autism and their families.
Toward Alignment: Defining What Matters
Ensuring that growth in autism services translates into meaningful improvements in care requires a redefinition of priorities. High-quality care must be grounded in clearly articulated standards that integrate medical, behavioral, and social dimensions across the lifespan. Outcomes must reflect functional independence, health status, quality of life, caregiver well-being, and continuity of care, rather than relying solely on measures of service utilization.
State-level autism frameworks further illustrate the gap between intention and implementation. For example, the New Jersey Autism State Plan outlines a vision grounded in family-driven, multidisciplinary, and functionally oriented care, emphasizing community inclusion and individualized service planning. However, as with many state systems, operationalization of this vision is largely mediated through eligibility criteria, provider qualifications, and reimbursement structures tied to diagnosis and medical necessity. While these mechanisms are necessary for system functioning, they can inadvertently shift focus toward service delivery metrics rather than meaningful outcomes. This tension highlights a broader systemic challenge: even well-designed policies risk falling short when financial and administrative structures are not fully aligned with person-centered goals (New Jersey Department of Children and Families, 2019).
The New Jersey Family Guide to Autism Services offers a parallel example. It reflects an earnest effort to help families navigate coverage and access, and it emphasizes individualized treatment planning, parental choice, care management, and coordination across systems. At the same time, the guide illustrates how even supportive service frameworks are largely operationalized through managed care organizations, prior authorizations, provider networks, and determinations of medical necessity, with treatment effectiveness monitored through administrative pathways rather than through a broader outcomes framework (New Jersey Department of Human Services, Division of Medical Assistance and Health Services, 2022).
Greater integration across pediatric, adult, and aging systems is essential, particularly as the population of adults with autism continues to grow. Workforce development must also be prioritized to ensure that clinicians across disciplines are equipped with the competencies necessary to provide IDD-informed care. At the same time, payment models must evolve to support coordination, complexity, and longitudinal care, aligning financial incentives with value rather than volume.
A Broader Reframing: From Market to System
The current moment presents an opportunity to move beyond the concept of an “autism market” toward a more comprehensive vision of a lifespan, person-centered neurodevelopmental care system. Such a system would integrate medical and behavioral care, address social determinants of health, and ensure equity across the full spectrum of intellectual and developmental disabilities.
Conclusion
The expansion of autism services reflects meaningful progress, including greater awareness, improved diagnosis, and increased access to care. However, growth alone is not synonymous with success.
The true measure of progress lies in whether expanded services lead to improved lives. In a healthcare system shaped by market forces, intentional leadership is required to ensure that financial incentives align with clinical realities and ethical responsibilities. The task ahead is not to oppose the market, but to shape it—so that it serves individuals with autism and intellectual and developmental disabilities in ways that are meaningful, equitable, and sustained across the lifespan.
About the Author
Dr. Seth Keller is a Neurologist at Neurology Associates of South Jersey. He specializes in the evaluation and care of adults with Intellectual and Developmental Disabilities (IDD) with neurologic complications. Dr. Keller is on the Executive Board of the Arc of Burlington County as well as on the board for The Arc of New Jersey Mainstreaming Medical Care Board. He is the co-president of the National Task Group on Intellectual Disabilities and Dementia Practices (NTG). He is also the founder and past chair of the Adult IDD Section with the American Academy of Neurology.
Dr. Keller is actively involved in national and international IDD health education as a speaker, and webinar and workshop participant. He is a co-author on a number of articles and book chapters relating to aging and dementia in those with IDD.
References
Agency for Healthcare Research and Quality. (2025). Applied behavior analysis interventions for autism spectrum disorder: Topic brief.
American Academy of Pediatrics. (2020). Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics, 145(1).
Mandell, D. S., & Novak, M. M. (2021). The evolving landscape of autism services. Annual Review of Public Health, 42, 421–436.
National Institute for Health and Care Excellence. (2021). Autism spectrum disorder in under 19s: Support and management.
New Jersey Department of Children and Families. (2019, January). New Jersey Autism State plan amendment.
New Jersey Department of Human Services, Division of Medical Assistance and Health Services. (2022, April). Family guide to autism services funded by Medicaid/NJ FamilyCare.
Oss, M. E. (2026, March 27). The autism market recalibration. OPEN MINDS.